IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Britigan, B. E.
Right arrow Articles by Cox, C. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Britigan, B. E.
Right arrow Articles by Cox, C. D.

 Previous Article  |  Next Article 

Infection and Immunity, March 1999, p. 1207-1212, Vol. 67, No. 3
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

The Pseudomonas aeruginosa Secretory Product Pyocyanin Inactivates alpha 1 Protease Inhibitor: Implications for the Pathogenesis of Cystic Fibrosis Lung Disease

Bradley E. Britigan,1,2,* Michelle A. Railsback,2 and Charles D. Cox3

Medical Service, VA Medical Center, Iowa City, Iowa 52246,1 and Departments of Internal Medicine2 and Microbiology,3 The University of Iowa College of Medicine, Iowa City, Iowa 52242

Received 10 September 1998/Returned for modification 19 October 1998/Accepted 18 December 1998


    ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

alpha 1 Protease inhibitor (alpha 1PI) modulates serine protease activity in the lung. Reactive oxygen species inactivate alpha 1PI, and this process has been implicated in the pathogenesis of a variety of forms of lung injury. An imbalance of protease-antiprotease activity is also detected in the airways of patients with cystic fibrosis-associated lung disease who are infected with Pseudomonas aeruginosa. P. aeruginosa secretes pyocyanin, which, through its ability to redox cycle, induces cells to generate reactive oxygen species. We tested the hypothesis that redox cycling of pyocyanin could lead to inactivation of alpha 1PI. When alpha 1PI was exposed to NADH and pyocyanin, a combination that results in superoxide production, alpha 1PI lost its ability to form an inhibitory complex with both porcine pancreatic elastase (PPE) and trypsin. Similarly, addition of pyocyanin to cultures of human airway epithelial cells to which alpha 1PI was also added resulted in a loss of the ability of alpha 1PI to form a complex with PPE or trypsin. Neither superoxide dismutase, catalase, nor dimethylthiourea nor depletion of the media of O2 to prevent formation of reactive oxygen species blocked pyocyanin-mediated inactivation of alpha 1PI. These data raise the possibility that a direct interaction between reduced pyocyanin and alpha 1PI is involved in the process. Consistent with this possibility, pretreatment of alpha 1PI with the reducing agent beta -mercaptoethanol also inhibited binding of trypsin to alpha 1PI. These data suggest that pyocyanin could contribute to lung injury in the P. aeruginosa-infected airway of cystic fibrosis patients by decreasing the ability of alpha 1PI to control the local activity of serine proteases.


    INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Tight regulation of local protease activity is critical to the maintenance of the physiologic function of the lung and other tissue sites (15, 40, 48). Serine proteases such as neutrophil elastase are among the proteases found within the human airway (15, 16, 20, 38, 40). Serine protease activity must be tightly regulated in order to protect local tissue from protease-mediated injury. This is accomplished in vivo through the presence of a group of proteins which specifically inhibit serine protease activity (32, 40, 48). Among the key antiproteases in the airway is alpha 1-protease inhibitor (alpha 1PI) (32, 40, 48). alpha 1PI is a 51-kDa protein member of the serpin class of serine protease inhibitors (32, 40, 48). alpha 1PI forms a nearly irreversible enzymatically inactive complex with various serine proteases, including human neutrophil elastase (HNE), porcine pancreatic elastase (PPE), and trypsin (29, 40, 48). The active site of alpha 1PI provides a putative cleavage site for the target enzymes, and it is the methionine 358 within that location which is key for both the protease specificity and inhibitory activity of alpha 1PI. Modifications of this methionine markedly decrease the inhibitory activity of alpha 1PI (29, 40, 48).

A number of laboratories have shown that exposure of alpha 1PI to various oxidant sources, including activated phagocytes (6, 14, 28, 34, 39, 50) and cigarette smoke (17, 41), results in rapid inactivation of the protein due to oxidation of methionine 358 (31). Since the hereditary decrease in alpha 1PI activity leads to early-onset emphysema (10), it has been postulated that oxidant-mediated inactivation of alpha 1PI, resulting in decreased local regulation of serine protease activity, is an important contributor to the pathophysiology of cigarette-associated chronic obstructive lung disease (6, 30).

An imbalance of protease-antiprotease activity is also detected in the airways of patients with cystic fibrosis-associated lung disease (5, 16, 18, 19, 35). Most of this elevated protease activity is due to an increase in HNE activity (23, 43, 45). Studies indicate that the untoward protease imbalance is a result of both elevated amounts of HNE and the presence of functionally inactive alpha 1PI (1, 2, 5, 35, 38, 44). The reason for the presence of inactive alpha 1PI is unclear.

The onset of progressive lung disease in cystic fibrosis usually coincides with the development of persistent colonization and infection of the airway with Pseudomonas aeruginosa. P. aeruginosa secretes a number of potentially cytotoxic factors, including the phenazine derivative pyocyanin (21, 24, 25, 51). Under aerobic conditions, exposure of pyocyanin to NADH or other cell-derived reducing equivalents, leads to redox cycling of the compound with resultant formation of superoxide (O2·-) and hydrogen peroxide (H2O2) (4, 11, 22, 24, 25). Given the ability of pyocyanin to induce oxidant production, we hypothesized that this P. aeruginosa-derived product could contribute to the pathogenesis of the protease-mediated component of cystic fibrosis lung disease by serving as an additional source of oxidant-mediated inactivation of alpha 1PI. The in vitro work reported herein supports the ability of redox cycling of pyocyanin to inactivate alpha 1PI. However, the mechanism may not directly involve oxidant production.


    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Reagents. NADH, CuZn superoxide dismutase (SOD), trypsin, porcine pancreatic elastase (PPE), H2O2, methionine, histidine, catalase, and dimethylthiourea (DMTU) were obtained from Sigma Chemical Co., St. Louis, Mo. alpha 1PI was purchased from Calbiochem, La Jolla, Calif. The PPE preparations contain chymotrypsin-trypsin (25 to 100 U of trypsin activity/mg of protein) as an impurity. 5,5 Dimethyl-N-pyrroline 1-oxide (DMPO) was purchased from the Oklahoma Medical Research Foundation, Oklahoma City, Okla.

Ability of alpha 1PI to form a complex with serine proteases. alpha 1PI (10 µg/ml) in H2O was incubated with either PPE (50 to 200 µg/ml) or trypsin (50 to 200 µg/ml) for 15 to 30 min at 37°C. Aliquots of the reaction mixture were then added to Laemmli solubilizing buffer and subjected to standard sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The results were similar regardless of whether or not the gels were run under reducing conditions. The alpha 1PI-protease complex is well known to remain associated under these conditions (7, 31, 46). Detection of an alpha 1PI-protease complex was assessed by either (i) staining the gel with silver and determining the presence or absence of a new band with an apparent molecular weight consistent with a complex of alpha 1PI and the protease; or (ii) transfer of the SDS-PAGE-separated sample to nitrocellulose. The nitrocellulose was then blocked with 4% bovine serum albumin-Tris-buffered saline for 1 h and then incubated overnight with a 1:100 dilution of rabbit anti-human alpha 1PI (Sigma). The blots were then washed three times, and immunoreactive protein was determined with antirabbit immunoglobulin G linked to alkaline phosphatase. The alpha 1PI-protease complex was manifested as the presence of an alpha 1PI immunoreactive band with an apparent molecular weight higher than that of an alpha 1PI standard.

alpha 1PI activity. alpha 1PI activity was measured in terms of alpha 1PI's ability to inhibit PPE-mediated cleavage of succinyl-L-alanyl-L-alanyl-L-alanyl-p-nitroanilide (Sigma) according to the spectrophotometric assay of Travis and Johnson (47).

Cell culture of human lung epithelial cells. The A549 human lung carcinoma cell line which resembles type II alveolar epithelial cells was maintained in continuous culture with Dulbecco's modification of Eagle's medium (DMEM) obtained through the University of Iowa Cancer Center, Iowa City. The culture medium was routinely supplemented with 10% heat-inactivated fetal bovine serum, 1% penicillin-streptomycin, and 1% glutamine. HBE cells were cultivated in a similar manner, except that the primary culture medium was 50% DMEM and 50% HAM (hepatocyte medium F12; University of Iowa Cancer Center). For each set of experiments, cells from the stock culture were seeded (2.5 × 104 to 5 × 104 cells/well) into 24- or 48-well plates. Cells were maintained at 37°C in 5% CO2 until they were at least 80% confluent (usually 72 h), at which time they were utilized in the desired experiments.

Purification of pyocyanin. Pyocyanin was extracted from culture supernatant of P. aeruginosa PAO1 (ATCC 15692; American Type Culture Collection, Rockville, Md.) by serial chloroform extractions followed by sequential extractions with acid and neutral water as previously detailed (9). After the completion of five separation sequences, the pyocyanin was crystallized and dried under vacuum. It was resuspended in water and stored at 4°C until used.

Effect of pyocyanin redox cycling on alpha 1PI-protease complex formation. Experiments were performed in which alpha 1PI (or, in some cases, the target protease) was exposed to either NADH- or cell-mediated redox cycling of pyocyanin. alpha 1PI (10 µg/ml) was added either to a solution of NADH (6 mM) in H2O or to an A549 or HBE cell monolayer in Hanks' balanced salt solution after which the desired concentration of pyocyanin was added. The system was then incubated for 30 min at 37°C. At this point, trypsin or PPE (200 µg/ml) was added for an additional 15 min (37°C). The solutions were assessed for the formation of alpha 1PI-protease complex as described above.

EPR and spin trapping. For spin trapping experiments, the spin trap DMPO (100 mM) and diethylenetriaminepentaacetic acid (DTPA [0.1 mM]) were included in the reaction mixture of interest. After the desired time of incubation, the reaction mixture was transferred to an electron paramagnetic resonance (EPR) quartz flat cell and placed into the cavity of the EPR spectrometer (ES 300; Brüker, Karlsrühe, Germany). EPR spectra were then obtained at 25°C with the following parameters: 4.00 × 109 gain, 335.544-s sweep time, 100-kHz modulation frequency, 0.501-G modulation amplitude, 80-G sweep width, 9.76-GHz frequency, and 20 mW of power. For detection of the pyocyanin radical, 40 µM pyocyanin was added to a 44 µM solution of NADH and 0.1 mM DTPA, which had been sparged with N2 for 20 min. The pyocyanin and NADH were then allowed to react at 25°C in the continuous presence of N2 and subjected to EPR spectroscopy with a Varian E-104A EPR spectrometer (Varian Associates, Inc., Palo Alto, Calif.) with a 1-s time constant, 8-min scan time, 2.5 × 104 gain, 100-kHz modulation frequency, and 20 mW of power.


    RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Pyocyanin-NADH blocks alpha 1PI-protease complex formation. Several laboratories, including our own, have shown that addition of NADH to pyocyanin leads to the reduction of pyocyanin to the pyocyanin radical (4, 11, 22, 24-26). Under aerobic conditions, the pyocyanin radical will transfer an electron to O2, leading to the formation of O2·- (4, 11, 22, 24-26). Consistent with these earlier data (4, 11, 22, 24-26), when NADH and pyocyanin were incubated under conditions in which O2 was previously depleted from the system by N2 bubbling, an EPR spectrum indicative of the pyocyanin radical was detected (data not shown). When the same reaction was performed under aerobic conditions, the pyocyanin radical was no longer seen, but O2.- production was readily detected by DMPO spin trapping (data not shown).

Given the susceptibility of alpha 1PI to inactivation by oxidant species (6, 17, 41, 52), the ability of NADH-mediated redox cycling of pyocyanin to decrease alpha 1PI activity was assessed. As shown in Fig. 1 and 2, the presence of NADH and pyocyanin decreased the ability of alpha 1PI to form a stable complex with either trypsin or PPE. Concentrations of pyocyanin required to completely prevent detectable complex formation varied from experiment to experiment, ranging from 25 to 125 µM. In the PPE experiments, a major protease-alpha 1PI complex (top) and a somewhat fainter protease-alpha 1PI complex (bottom) were routinely observed. The lower bands are likely due to the presence of chymotrypsin and/or trypsin, which routinely contaminate commercial PPE preparations and also form a complex with alpha 1PI. Neither NADH nor pyocyanin alone prevented formation of the alpha 1PI-protease complex (data not shown), indicating that reduction of pyocyanin was required. These results were similar, regardless of whether the alpha 1PI-protease complex was detected by silver staining or immunoblot analysis.


View larger version (88K):
[in this window]
[in a new window]
 
FIG. 1.   Immunoblot with antisera to alpha 1PI in which gel samples were comprised of 10 µg of alpha 1PI alone (lane 1); alpha 1PI which had been incubated with trypsin for 30 min at 37°C (lane 2); or alpha 1PI and 200 µg of trypsin along with 6 mM NADH and pyocyanin at a concentration of 12.5 µM (lane 3), 50 µM (lane 4), and 100 µM (lane 5). The arrow designates the location of the complex formed by alpha 1PI and trypsin. The results are representative of 10 experiments.


View larger version (81K):
[in this window]
[in a new window]
 
FIG. 2.   Immunoblot with antisera to alpha 1PI. The gel sample in lane 1 consisted of alpha 1PI which had been incubated for 30 min at 37°C with 200 µg of PPE. Lane 2 shows results obtained under the same conditions as lane 1, except that 6 mM NADH and 100 µM pyocyanin were added prior to the addition of PPE to the reaction mixture. The results are representative of five separate experiments.

An additional feature frequently noted when the NADH-pyocyanin combination was present was a decrease in the apparent quantity of alpha 1PI detectable on the gel and evidence of proteolytic degradation products of alpha 1PI (Fig. 1 and 2). The fact that these were detected by anti-alpha 1PI immunoblotting indicates they indeed reflect degradation of alpha 1PI. Lower-molecular-weight bands reactive with anti-alpha 1PI were not observed with NADH-pyocyanin-treated alpha 1PI unless an active protease was also added to the reaction mixture (data not shown [n = 3]). These data are consistent with the hypothesis that NADH-pyocyanin exposure leads to a modification of alpha 1PI, such that the antiprotease is converted to a legitimate substrate for PPE or trypsin.

Since the incubation conditions described above resulted in exposure of trypsin and PPE to NADH-pyocyanin as well as alpha 1PI, experiments were performed so that we could be certain that the effect of NADH-pyocyanin was on alpha 1PI and not the protease. alpha 1PI-protease complex formation was compared under conditions in which alpha 1PI or the protease was first exposed to NADH-pyocyanin for 30 min, after which, the protease or alpha 1PI was then added to the system, respectively, and alpha 1PI-protease complex formation was assessed (Fig. 3). When alpha 1PI was first incubated with NADH-pyocyanin and then PPE or trypsin was added, no alpha 1PI-protease complex was generated (Fig. 3). In contrast, when trypsin or PPE was the component incubated initially with NADH-pyocyanin, after which alpha 1PI was added, the same magnitude of alpha 1PI-protease complex was observed as in the non-NADH-pyocyanin-treated control (Fig. 3). These results indicate that the effect of NADH-pyocyanin is on alpha 1PI rather than the protease.


View larger version (39K):
[in this window]
[in a new window]
 
FIG. 3.   Immunoblot with antisera to alpha 1PI in which gel samples were comprised of 10 µg of alpha 1PI plus 200 µg of trypsin which had been incubated for 30 min at 37°C. Lanes 1 to 3 show the results obtained when alpha 1PI was previously exposed to 6 mM NADH and 100 µM pyocyanin alone (lane 1), or with SOD (300 U/ml; lane 2) or catalase (5,000 U/ml; lane 3) added, for 20 min prior to the addition of trypsin to the reaction mixture. Samples in lanes 4 to 6 were obtained under the same conditions as those of lanes 1 to 3, except that the trypsin rather than the alpha 1PI was previously exposed to 6 mM NADH and 100 µM pyocyanin alone (lane 4), or with SOD (300 U/ml; lane 5) or catalase (5,000 U/ml; lane 6) added, for 30 min prior to its interaction with alpha 1PI. The results are representative of three experiments.

Biochemical evidence of NADH-pyocyanin inactivation of alpha 1PI. As confirmation that exposure to NADH-pyocyanin leads to loss of alpha 1PI functional activity, the ability of NADH-pyocyanin-treated alpha 1PI to inhibit PPE enzymatic activity was assessed. alpha 1PI exposed to NADH-pyocyanin exhibited an impaired ability to inhibit PPE cleavage of succinyl-L-alanyl-L-alanyl-L-alanyl-p-nitroanilide. In the absence of alpha 1PI, cleavage of succinyl-L-alanyl-L-alanyl-L-alanyl-p-nitroanilide by PPE yielded a change in A410 of 0.132 ± 0.012 U/min (mean ± standard error [SE]; n = 10). Addition of alpha 1PI decreased this to 0.040 ± 0.005 U/min (mean ± SE; n = 10). When alpha 1PI was first exposed to NADH-pyocyanin for 10 min, its ability to inhibit PPE activity was significantly decreased (P < 0.001 by analysis of variance) because A410 was 0.076 ± 0.009 U/min (mean ± SE; n = 10). NADH-pyocyanin had no effect on PPE activity as assessed in this assay (data not shown).

Epithelial cell-mediated redox cycling of pyocyanin inactivates alpha 1PI. In vivo redox cycling of pyocyanin in the P. aeruginosa-infected airway would likely occur via epithelial cell-mediated reduction of the compound rather via its interaction with extracellular NADH or NADPH. We have previously shown that incubation of monolayers of A549 (3, 12, 37) or HBE cells (12) with pyocyanin results in the formation of O2·-, as detected by spin trapping. Since initial reduction of pyocyanin would likely occur intracellularly, it was unclear whether cell-mediated redox cycling of pyocyanin could inactivate extracellular alpha 1PI. In order to assess this, A549 (or HBE) monolayers were incubated with alpha 1PI (10 µg/ml) ± pyocyanin (10 to 200 µM) for 30 min. PPE or trypsin was then added, and after 15 min of additional incubation, formation of alpha 1PI-protease complex in the extracellular milieu was assessed by immunoblot analysis. As shown in Fig. 4 and 5, the presence of pyocyanin resulted in a marked decrease in the subsequent ability of alpha 1PI to form a complex with either trypsin or PPE. This was dependent on the concentration of pyocyanin present. As with NADH-pyocyanin, supernatants from pyocyanin-treated, but not control, epithelial cells often exhibited evidence of alpha 1PI proteolysis (Fig. 4).


View larger version (57K):
[in this window]
[in a new window]
 
FIG. 4.   Immunoblot with antisera to alpha 1PI in which gel samples were comprised of supernatants removed from monolayers of HBE cells 30 min following the addition of alpha 1PI (lane 1), alpha 1PI plus 50 µM pyocyanin (lane 2), and alpha 1PI plus 200 µM pyocyanin (lane 3), which were then mixed with trypsin for 30 min at 37°C. Each sample was subjected to SDS-PAGE and immunoblot analysis as described in Materials and Methods. The results are representative of three experiments.


View larger version (52K):
[in this window]
[in a new window]
 
FIG. 5.   Immunoblot with antisera to alpha 1PI in which gel samples were comprised of supernatants removed from monolayers of A549 cells 30 min following the addition of alpha 1PI (lane 2) or alpha 1PI plus 100 µM pyocyanin (lane 3), which were then mixed with trypsin for 30 min at 37°C. The samples were then subjected to SDS-PAGE and immunoblot analysis as described in Materials and Methods. Lane 1 contains only alpha 1PI, which was not incubated with trypsin and is included as a reference. The results are representative of three experiments.

Role of reactive oxygen intermediates in pyocyanin-associated inactivation of alpha 1PI. The ability of neutrophils to inactivate alpha 1PI is linked to oxidation of the protein by reactive oxygen species, particularly those arising from the reaction of H2O2 and myeloperoxidase (MPO) (6, 14, 34, 52). Accordingly, we postulated that oxidant species resulting from pyocyanin-induced O2·- formation were responsible for NADH-pyocyanin-mediated inhibition of alpha 1PI activity. In order to test this, we determined if the presence of SOD, catalase, or the H2O2-hydroxyl radical scavenger DMTU blocked NADH-pyocyanin-mediated inactivation of alpha 1PI. Surprisingly, none of these agents alone nor the combination of SOD and catalase exhibited any ability to block the effect of NADH-pyocyanin (Fig. 3). SOD and catalase are reasonably large proteins, raising the possibility that they were unable to adequately reach the site of alpha 1PI which required protection. However, we found that methionine, which blocks MPO-mediated inactivation of alpha 1PI (6) via its ability to spare methionine 358 within the active site of alpha 1PI (6, 29, 40, 48), did not protect alpha 1PI from the effects of NADH-pyocyanin (data not shown). In addition, since O2·- is not generated as a consequence of pyocyanin reduction under anaerobic conditions, we assessed the ability of O2 depletion on the process by bubbling the experimental system with N2 prior to the addition of pyocyanin. NADH-pyocyanin retained its ability to inactivate alpha 1PI under O2-depleted conditions (Fig. 6). That bubbling of N2 effectively depleted the system of O2 was confirmed with the anaerobic indicator resazurin (33).


View larger version (48K):
[in this window]
[in a new window]
 
FIG. 6.   Immunoblot with antisera to alpha 1PI in which gel samples were comprised of 10 µg of alpha 1PI alone (lane 1) or 10 µg of alpha 1PI alone plus 200 µg of trypsin (lane 2), which had been incubated for 30 min at 37°C. Lanes 3 and 4 show results obtained under the same conditions as lane 2, except that 6 mM NADH and 100 µM pyocyanin were added prior to the addition of trypsin to the reaction mixture. The incubation in lane 3 was performed under standard aerobic conditions, whereas lane 4 reflects results obtained under O2-depleted conditions in which the reaction mixture was bubbled with N2 for 20 min prior to the addition of pyocyanin. The results are representative of three separate experiments.

These data do not suggest a role for O2·-, or subsequently generated oxidants such as H2O2, in the ability of reduced pyocyanin to inactivate alpha 1PI. Instead, they raise the possibility that pyocyanin radical, a reducing species formed by the initial electron transfer from NADH to pyocyanin, could be inactivating alpha 1PI via a reducing rather than an oxidizing reaction. In support of this, exposure of alpha 1PI to the reducing agent beta -mercaptoethanol resulted in an inability of the alpha 1PI to subsequently bind trypsin (Fig. 7). This is in contrast to reports in the literature (7, 31, 46) and or own experience (data not shown) that, once formed, the alpha 1PI-trypsin complex does not dissociate upon exposure to beta -mercaptoethanol.


View larger version (77K):
[in this window]
[in a new window]
 
FIG. 7.   Immunoblot with antisera to alpha 1PI in which gel samples were comprised of 10 µg of alpha 1PI alone (lane 1) or 10 µg of alpha 1PI alone plus 200 µg of trypsin (lane 2), which had been incubated for 30 min at 37°C. The reaction in lane 3 was performed under the same conditions as those of lane 2, except that the alpha 1PI had been exposed to 14 mM beta -mercaptoethanol prior to the addition of the trypsin. Although not shown in this figure, addition of beta -mercaptoethanol after the completion of the incubation of trypsin and alpha 1PI has no effect on complex formation.


    DISCUSSION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

An elevated ratio of protease to antiprotease activity has been detected in the P. aeruginosa-infected airways of cystic fibrosis patients, and this is felt to contribute to the pathogenesis of cystic fibrosis lung disease (23, 43, 45). This imbalance is likely due to the presence of markedly elevated levels of the serine protease HNE as well as a higher than expected frequency of inactive alpha 1PI (1, 2, 5, 35, 38, 44). Given the known susceptibility of alpha 1PI to oxidant-mediated inactivation (6, 14, 17, 34, 41, 52), the ability of the redox-active P. aeruginosa secretory product pyocyanin to inactivate alpha 1PI was assessed. Such a process could contribute to protease-mediated lung injury in cystic fibrosis, as well as potentially necrotizing acute nosocomial P. aeruginosa. Nearly all strains of P. aeruginosa are capable of producing pyocyanin.

In support of this hypothesis, we found that the reaction of NADH with concentrations of pyocyanin reported to be present in sputum sol of P. aeruginosa-infected cystic fibrosis patients (51), in excess of 100 µM, was able to alter alpha 1PI such that it was no longer able to bind to and inhibit the enzymatic activity of the serine proteases PPE and trypsin (binding studies only). The concentration of pyocyanin present in the lung in the setting of P. aeruginosa pneumonia in the non-cystic fibrosis-hospitalized patient is not known. Our studies were performed with concentrations of alpha 1PI and serine proteases very close to the mean values of 12 and 88 µg of alpha 1PI and human neutrophil elastase, respectively, per ml reported to be present in the sputum of P. aeruginosa-infected cystic fibrosis patients (38). Although we would expect a similar effect of pyocyanin exposure on alpha 1PI binding to HNE, this was not assessed due to the cost-prohibitive requirement of HNE for such studies. alpha 1PI binding to all serine proteases occurs via the same basic process (32, 40, 48).

Similar to the results with NADH-pyocyanin, in studies in which human lung epithelial cell monolayers were exposed to pyocyanin, alpha 1PI was inactivated when the protein was present in the extracellular milieu. Thus, in spite of the intracellular site at which pyocyanin reduction likely occurs, there was sufficient interaction between reduced pyocyanin and/or its oxidant products to inactivate alpha 1PI. Previous spin trapping studies with endothelial cells support the concept that these pyocyanin-derived products do have access to the extracellular space (4).

Regardless of whether NADH or epithelial cells were employed as the means of reducing pyocyanin, incubation of pyocyanin-treated alpha 1PI with either trypsin or PPE resulted in the formation of proteolytic degradation products of alpha 1PI. This suggests that redox cycling of pyocyanin leads to modifications of alpha 1PI which allow it to be cleaved by the protease rather than resulting in the formation of an irreversible complex between alpha 1PI and the protease. Oxidant-mediated inactivation of another airway protease inhibitor, secretory leukocyte protease inhibitor (SLPI), also renders it more susceptible to proteolysis (49).

Consistent with our previous work (3, 4, 37) and that of others (4, 8, 11, 22, 24-26, 42), we found by using EPR techniques that the addition of NADH to pyocyanin leads to the initial formation of pyocyanin radical, which in the presence of O2 transfers that electron to O2 to form O2·-. O2·- production was also observed upon the addition of pyocyanin to human airway epithelial cells. Although not specifically measured, production of O2·- would lead in turn to the formation of H2O2 via the dismutation reaction of O2·- with itself (36). In view of previous observations that oxidation of methionine 358 at the alpha 1PI active site is the mechanism whereby MPO-H2O2 inactivates alpha 1PI (29, 40, 48), we suspected a similar process was involved in the inactivation of alpha 1PI by pyocyanin. However, several pieces of data argue against such a mechanism. Free methionine failed to protect alpha 1PI from the effect of pyocyanin, in contrast to its reported ability to protect the protein from inactivation by the MPO-H2O2 system (6). Neither SOD, catalase, DMTU, nor depletion of O2 from the system altered the ability of NADH-pyocyanin to inactivate alpha 1PI. These data argue strongly against a role for pyocyanin-derived O2·- and/or H2O2 in the ability of this P. aeruginosa-derived compound to inactivate alpha 1PI. Thus, pyocyanin-mediated inactivation of alpha 1PI inhibition does not likely occur via oxidation of methionine at the alpha 1PI active site.

These data raise the possibility that a direct interaction between alpha 1PI and the pyocyanin radical itself, rather than reactive oxidant species generated from the interaction of reduced pyocyanin and O2, modifies alpha 1PI such that it loses its ability to bind serine proteases. Under this hypothesis, the pyocyanin radical would directly modify alpha 1PI by the transfer of an electron (reduction) to an amino acid constituent of the protein resulting in either direct modification of the active site or alternatively a conformational change in the molecule that decreases its ability to irreversibly bind serine proteases. This is consistent with the fact that the pyocyanin radical is predominantly a reducing radical. Supporting this hypothesis, exposure to the reducing agent beta -mercaptoethanol also resulted in a loss of the ability of alpha 1PI to bind trypsin. We are unaware of studies investigating the potential for reduction rather than oxidation of alpha 1PI to decrease its ability to bind serine proteases. What amino acid(s) would be the target of such reduction is difficult to predict. This hypothesis will need to be further examined with previously generated site-specific mutations of alpha 1PI as well as by molecular analysis of the pyocyanin-modified protein.

Although the exact mechanism remains to be definitively defined, our data are consistent with the potential for pyocyanin present in the P. aeruginosa-infected airway to cause a local inhibition of alpha 1PI activity, thereby contributing to protease-mediated tissue injury. It is likely that the pathophysiology responsible for the protease-antiprotease imbalance which marks the airway of cystic fibrosis patients is multifactorial. There is an increased burden of HNE due to the large neutrophilic infiltrate that marks this disease state. Oxidants produced by the same neutrophils, particularly those derived from MPO-H2O2, also likely serve to inactivate alpha 1PI. Interestingly, recent data suggest that pyocyanin, through its ability to induce interleukin 8 release from airway epithelial cells, may contribute to this neutrophilic infiltration of the airway (13). Besides alpha 1PI, the airway contains other antiproteases, such as (SLPI), capable of inhibiting HNE (49). SLPI is also susceptible to oxidant-mediated inactivation (27, 49) due to the presence of a methionine residue at its active site. Whether SLPI can also be inactivated by pyocyanin is unknown and is worthy of investigation.

In summary, the present work demonstrates that, once reduced, pyocyanin can in turn interact with alpha 1PI in such a way that there is a loss of the protein's ability to form an irreversible complex with and inhibit the enzymatic activity of serine proteases. Although the exact mechanism requires further delineation, occurrence of these events in vivo could contribute to the pathogenesis of serine protease-mediated injury in P. aeruginosa-infected lungs of patients with cystic fibrosis chronic lung disease and/or acute nosocomial P. aeruginosa pneumonia.


    ACKNOWLEDGMENTS

This work was supported in part by research grants from the Office of Research and Development, Medical Research Service, Department of Veteran Affairs, and the Public Health Service (HL44275 and AI34954), as well as the Cystic Fibrosis Foundation, and was performed during the tenure of B.E.B. as an Established Investigator of the American Heart Association.

We acknowledge and thank George Rasmussen for performing the spin trapping studies and Gerene Denning for helpful discussions.


    FOOTNOTES

* Corresponding author. Mailing address: Department of Medicine, The University of Iowa, 200 Hawkins Dr., SW54 GH, Iowa City, IA 52242. Phone: (319) 356-2883. Fax: (319) 356-4600. E-mail: bradley-britigan{at}mail.int-med.uiowa.edu.

Editor:   E. I. Tuomanen


    REFERENCES
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

1. Allen, E. D. 1996. Opportunities for the use of aerosolized alpha 1-antitrypsin for the treatment of cystic fibrosis. Chest 110(Suppl.):256S-260S[Medline].
2. Birrer, P., N. G. McElvaney, A. Rüdeberg, C. Wirz Sommer, S. Liechti-Gallati, R. Kraemer, R. Hubbard, and R. G. Crystal. 1994. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 150:207-213[Abstract].
3. Britigan, B. E., G. T. Rasmussen, and C. D. Cox. 1997. Augmentation of oxidant injury to human pulmonary epithelial cells by the Pseudomonas aeruginosa siderophore pyochelin. Infect. Immun. 65:1071-1076[Abstract].
4. Britigan, B. E., T. L. Roeder, G. T. Rasmussen, D. M. Shasby, M. L. McCormick, and C. D. Cox. 1992. Interaction of the Pseudomonas aeruginosa secretory products pyocyanin and pyochelin generates hydroxyl radical and causes synergistic damage to endothelial cells: implications for pseudomonas-associated tissue injury. J. Clin. Investig. 90:2187-2196.
5. Bruce, M. C., L. Poncz, J. D. Klinger, R. C. Stern, J. F. Tomashefski, Jr., and D. G. Dearborn. 1985. Biochemical and pathologic evidence for proteolytic destruction of lung connective tissue in cystic fibrosis. Am. Rev. Respir. Dis. 132:529-535[Medline].
6. Carp, H., and A. Janoff. 1979. In vitro suppression of serum-elastase-inhibitory capacity by reactive oxygen species generated by phagocytosing polymorphonuclear leukocytes. J. Clin. Investig. 63:793-797.
7. Christensen, S., Z. Valnickova, I. B. Thogersen, S. V. Pizzo, H. R. Nielsen, P. Roepstorff, and J. J. Enghild. 1995. Sodium dodecyl sulfate-stable complexes between serpins and active or inactive proteinases contain the region COOH-terminal to the reactive site loop. J. Biol. Chem. 270:14859-14862[Abstract/Free Full Text].
8. Cohen, M. S., L. M. Charniga, M. J. Stutts, J. R. Yankaskas, D. J. Hassett, E. Krochmal, J. T. Gatzy, and R. C. Boucher. 1990. Effects of Pseudomonas pyocyanin on cystic fibrosis epithelial cells, abstr. 44, p. 94. In Program and abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
9. Cox, C. D. 1986. Role of pyocyanin in the acquisition of iron from transferrin. Infect. Immun. 52:263-270[Abstract/Free Full Text].
10. Crystal, R. G. 1990. alpha -1-Antitrypsin deficiency, emphysema, and liver disease: genetic basis and strategies for therapy. J. Clin. Investig. 85:1342-1352.
11. Davis, G., and P. J. Thornalley. 1983. Free radical production from the aerobic oxidation of reduced pyridine nucleotides catalyzed by phenazine derivatives. Biochim. Biophys. Acta 724:456-464[Medline].
12. Denning, G. M., M. A. Railsback, G. T. Rasmussen, C. D. Cox, and B. E. Britigan. 1998. Pseudomonas pyocyanine alters calcium signaling in human airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 274:L893-L900[Abstract/Free Full Text].
13. Denning, G. M., L. A. Wollenweber, M. A. Railsback, C. D. Cox, L. L. Stoll, and B. E. Britigan. 1998. Pseudomonas pyocyanin increases interleukin-8 expression by human airway epithelial cells. Infect. Immun. 66:5777-5784[Abstract/Free Full Text].
14. Desrochers, P. E., K. Mookhtiar, H. E. Van Wart, K. A. Hasty, and S. J. Weiss. 1992. Proteolytic inactivation of alpha 1-proteinase inhibitor and alpha 1-antichymotrypsin by oxidatively activated human neutrophil metalloproteinases. J. Biol. Chem. 267:5005-5012[Abstract/Free Full Text].
15. Döring, G. 1994. The role of neutrophil elastase in chronic inflammation. Am. J. Respir. Crit. Care Med. 150(Suppl.):S114-S117.
16. Döring, G., W. Goldstein, A. Röll, P. O. Schiøtz, N. Høiby, and K. Botzenhart. 1985. Role of Pseudomonas aeruginosa exoenzymes in lung infections of patients with cystic fibrosis. Infect. Immun. 49:557-562[Abstract/Free Full Text].
17. Evans, M. D., D. F. Church, and W. A. Pryor. 1991. Aqueous cigarette tar extracts damage human alpha-1-proteinase inhibitor. Chem. Biol. Interact. 79:151-164[Medline].
18. Fick, R. B., Jr. 1989. Pathogenesis of the Pseudomonas lung lesion in cystic fibrosis. Chest 96:158-164[Free Full Text].
19. Fick, R. B., Jr., and J. S. Hata. 1989. Pathogenetic mechanisms in lung disease caused by Pseudomonas aeruginosa. Chest 95:206S-213S[Free Full Text].
20. Fick, R. B., Jr., G. P. Naegel, S. U. Squier, R. E. Wood, J. B. L. Gee, and H. Y. Reynolds. 1984. Proteins of the cystic fibrosis respiratory tract: fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis. J. Clin. Investig. 74:236-248.
21. Frank, L. H., and R. D. DeMoss. 1959. On the biosynthesis of pyocyanine. J. Bacteriol. 77:776-782[Free Full Text].
22. Gardner, P. R. 1996. Superoxide production by the mycobacterial and pseudomonad quinoid pigments phthiocol and pyocyanine in human lung cells. Arch. Biochem. Biophys. 333:267-274[Medline].
23. Goldstein, W., and G. Doring. 1986. Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis. Am. Rev. Respir. Dis. 134:49-56[Medline].
24. Hassan, H. M., and I. Fridovich. 1979. Intracellular production of superoxide radical and hydrogen peroxide by redox active compounds. Arch. Biochem. Biophys. 196:385-395[Medline].
25. Hassan, H. M., and I. Fridovich. 1980. Mechanism of the antibiotic action of pyocyanine. J. Bacteriol. 141:156-163[Abstract/Free Full Text].
26. Hassett, D. J., L. Charniga, K. Bean, D. E. Ohman, and M. S. Cohen. 1992. Response of Pseudomonas aeruginosa to pyocyanin: mechanisms of resistance, antioxidant defenses, and demonstration of a manganese-cofactored superoxide dismutase. Infect. Immun. 60:328-336[Abstract/Free Full Text].
27. Heinzel-Wieland, R., G. J. Steffens, and L. Flohé. 1990. Inhibitory characteristics and oxidation resistance of site-specific variants of recombinant human antileukoproteinase. Biomed. Biochim. Acta 50:677-681.
28. Hubbard, R. C., F. Ogushi, G. A. Fells, A. M. Cantin, S. Jallat, M. Courtney, and R. G. Crystal. 1987. Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha 1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase. J. Clin. Investig. 80:1289-1295.
29. Huber, R., and R. W. Carrell. 1989. Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins. Biochemistry 28:8951-8966[Medline].
30. Janoff, A., H. Carp, P. Laurent, and L. Raju. 1983. The role of oxidative processes in emphysema. Am. Rev. Respir. Dis. 127:S31-S38[Medline].
31. Johnson, D., and J. Travis. 1979. The oxidative inactivation of human alpha -1-proteinase inhibitor: further evidence for methionine at the reactive center. J. Biol. Chem. 254:4022-4026[Free Full Text].
32. Kraut, J. 1977. Serine proteases: structure and mechanism of catalysis. Annu. Rev. Biochem. 46:331-358[Medline].
33. Mandell, G. L. 1974. Bactericidal activity of aerobic and anaerobic polymorphonuclear neutrophils. Infect. Immun. 9:337-341[Abstract/Free Full Text].
34. Matheson, N. R., P. S. Wong, and J. Travis. 1979. Enzymatic inactivation of human alpha -1-proteinase inhibitor by neutrophil myeloperoxidase. Biochem. Biophys. Res. Commun. 88:402-409[Medline].
35. Meyer, K. C., J. R. Lewandoski, J. J. Zimmerman, D. Nunley, W. J. Calhoun, and G. A. Dopico. 1991. Human neutrophil elastase and elastase/alpha1-antiprotease complex in cystic fibrosis: comparison with interstitial lung disease and evaluation of the effect of intravenously administered antibiotic therapy. Am. Rev. Respir. Dis. 144:580-585[Medline].
36. Miller, R. A., and B. E. Britigan. 1995. The formation and biologic significance of phagocyte-derived oxidants. J. Investig. Med. 43:39-49[Medline].
37. Miller, R. A., G. T. Rasmussen, C. D. Cox, and B. E. Britigan. 1996. Protease cleavage of iron-transferrin augments pyocyanin-mediated endothelial cell injury via promotion of hydroxyl radical formation. Infect. Immun. 64:182-188[Abstract].
38. O'Connor, C. M., K. Gaffney, J. Keane, A. Southey, N. Byrne, S. O'Mahoney, and M. X. Fitzgerald. 1993. alpha 1-Proteinase inhibitor, elastase activity, and lung disease severity in cystic fibrosis. Am. Rev. Respir. Dis. 148:1665-1670[Medline].
39. Ossanna, P. J., S. T. Test, N. R. Matheson, S. Regiani, and S. J. Weiss. 1986. Oxidative regulation of neutrophil elastase-alpha-a-proteinase inhibitor interactions. J. Clin. Investig. 77:1939-1951.
40. Potempa, J., E. Korzus, and J. Travis. 1994. The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J. Biol. Chem. 269:15957-15960[Free Full Text].
41. Pryor, W. A., M. M. Dooley, and D. F. Church. 1986. The inactivation of alpha -1-proteinase inhibitor by gas-phase cigarette smoke: protection by antioxidants and reducing species. Chem. Biol. Interact. 57:271-283[Medline].
42. Schellhorn, H. E., S. Pou, C. Moody, and H. M. Hassan. 1989. An electron spin resonance study of oxyradical generation in superoxide dismutase- and catalase-deficient mutants of Escherichia coli K-12. Arch. Biochem. Biophys. 271:323-331[Medline].
43. Suter, S. 1989. The imbalance between granulocyte neutral proteases and antiproteases in bronchial secretions from patients with cystic fibrosis. Antibiot. Chemother. 42:158-168[Medline].
44. Suter, S. 1994. The role of bacterial proteases in the pathogenesis of cystic fibrosis. Am. J. Respir. Crit. Care Med. 150(Suppl.):S118-S122.
45. Suter, S., O. B. Schaad, L. Roux, U. E. Nydegger, and F. A. Waldvogel. 1984. Granulocyte neutral proteases and Pseudomonas elastase as possible causes of airway damage in patients with cystic fibrosis. J. Infect. Dis. 149:523-531[Medline].
46. Thomas, R. M., W. M. Nauseef, S. S. Iyer, M. W. Peterson, P. J. Stone, and R. A. Clark. 1991. A cytosolic inhibitor of human neutrophil elastase and cathepsin G. J. Leukocyte Biol. 50:568-579[Abstract].
47. Travis, J., and D. Johnson. 1981. Human alpha 1-proteinase inhibitor. Methods Enzymol. 80:754-765.
48. Travis, J., and G. S. Salvesen. 1983. Human plasma proteinase inhibitors. Annu. Rev. Biochem. 52:655-709[Medline].
49. Vogelmeier, C., R. C. Hubbard, G. A. Fells, H.-P. Schnebli, R. C. Thompson, H. Fritz, and R. G. Crystal. 1991. Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor. J. Clin. Investig. 87:482-488.
50. Weiss, S. J., and S. Regiani. 1984. Neutrophils degrade subendothelial matrices in the presence of alpha-1-proteinase inhibitor. Cooperative use of lysosomal proteinases and oxygen metabolites. J. Clin. Investig. 73:1297-1303.
51. Wilson, R., D. A. Sykes, D. Watson, A. Rutman, G. W. Taylor, and P. J. Cole. 1988. Measurement of Pseudomonas aeruginosa phenazine pigments in sputum and assessment of their contribution to sputum sol toxicity for respiratory epithelium. Infect. Immun. 56:2515-2517[Abstract/Free Full Text].
52. Zaslow, M. C., R. A. Clark, P. J. Stone, J. D. Calore, G. L. Snider, and C. Franzblau. 1983. Human neutrophil elastase does not bind alpha1-protease inhibitor that has been exposed to activated human neutrophils. Am. Rev. Respir. Dis. 128:434-439[Medline].


Infection and Immunity, March 1999, p. 1207-1212, Vol. 67, No. 3
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Britigan, B. E.
Right arrow Articles by Cox, C. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Britigan, B. E.
Right arrow Articles by Cox, C. D.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol.